US EditionMiR-342-3p Is a Novel Biomarker for the Diagnosis and Regulates Tumorigenesis in Thyroid Papillary Cancer Through FOXQ1
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
MiR-342-3p is a novel biomarker for the diagnosis and regulates tumorigenesis in thyroid papillary cancer through FOXQ1
The downregulated level of miR-342-3p has been reported in various kinds of human malignancies. It remains unclear the biological function of miR-342-3p in PTC. The purpose of this work aimed to assess the expression pattern of miR-342-3p and determine its potential role as biomarker in PTC, f...
Multi-Omics Reveal Thyroid Cancer Subtypes for Precision Care
In a groundbreaking advance for thyroid cancer research, scientists have successfully delineated two distinct molecular subtypes of thyroid carcinoma using a comprehensive multi-omics approach. This cutting-edge study, analyzing data from 539 patients, integrates DNA methylation, gene mutation profiles, and RNA expression analyses encompassing mRNA, lncRNA, and miRNA, revealing novel insights into the disease’s complexity and offering promising …
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
